167 related articles for article (PubMed ID: 2501817)
1. Acute effects of high-dose thyrotropin releasing hormone infusions in Alzheimer's disease.
Mellow AM; Sunderland T; Cohen RM; Lawlor BA; Hill JL; Newhouse PA; Cohen MR; Murphy DL
Psychopharmacology (Berl); 1989; 98(3):403-7. PubMed ID: 2501817
[TBL] [Abstract][Full Text] [Related]
2. Pressor, norepinephrine, and pituitary responses to two TRH doses in Alzheimer's disease and normal older men.
Lampe TH; Veith RC; Plymate SR; Risse SC; Kopeikin H; Cubberley L; Raskind MA
Psychoneuroendocrinology; 1989; 14(4):311-20. PubMed ID: 2510210
[TBL] [Abstract][Full Text] [Related]
3. Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans.
Molchan SE; Hill JL; Minichiello M; Vitiello B; Sunderland T
Life Sci; 1994; 54(13):933-8. PubMed ID: 8139380
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose TRH on cognitive deficits in the ECT postictal state.
Khan A; Mirolo MH; Claypoole K; Bhang J; Cox G; Horita A; Tucker G
Am J Psychiatry; 1994 Nov; 151(11):1694-6. PubMed ID: 7943463
[TBL] [Abstract][Full Text] [Related]
5. TRH attenuates scopolamine-induced memory impairment in humans.
Molchan SE; Mellow AM; Lawlor BA; Weingartner HJ; Cohen RM; Cohen MR; Sunderland T
Psychopharmacology (Berl); 1990; 100(1):84-9. PubMed ID: 2104988
[TBL] [Abstract][Full Text] [Related]
6. Thyrotropin-releasing hormone (TRH) and Alzheimer's disease.
Peabody CA; Deblois TE; Tinklenberg JR
Am J Psychiatry; 1986 Feb; 143(2):262-3. PubMed ID: 3080909
[No Abstract] [Full Text] [Related]
7. Low-dose thyrotropin-releasing hormone effects in cognitively impaired alcoholics.
Khan A; Mirolo MH; Claypoole K; Hughes D
Alcohol Clin Exp Res; 1993 Aug; 17(4):791-6. PubMed ID: 8214416
[TBL] [Abstract][Full Text] [Related]
8. The therapeutic potential of thyrotropin releasing hormone (TRH) in Alzheimer's disease (AD).
Yarbrough GG; Pomara N
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(3):285-9. PubMed ID: 3929331
[TBL] [Abstract][Full Text] [Related]
9. A peptide enhancement strategy in Alzheimer's disease: pilot study with TRH-physostigmine infusions.
Mellow AM; Aronson SM; Giordani B; Berent S
Biol Psychiatry; 1993 Aug; 34(4):271-3. PubMed ID: 8399826
[No Abstract] [Full Text] [Related]
10. Thyrotropin-releasing hormone (TRH) inchronic schizophrenia. A controlled study.
Lindström LH; Gunne LM; Ost LG; Persson E
Acta Psychiatr Scand; 1977 Jan; 55(1):74-80. PubMed ID: 402794
[TBL] [Abstract][Full Text] [Related]
11. Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials.
Mitsumoto H; Salgado ED; Negroski D; Hanson MR; Salanga VD; Wilber JF; Wilbourn AJ; Breuer AC; Leatherman J
Neurology; 1986 Feb; 36(2):152-9. PubMed ID: 3080695
[TBL] [Abstract][Full Text] [Related]
12. Intravenous thyrotropin releasing hormone in amyotrophic lateral sclerosis: autonomic effects.
Beaulieu DA; Erickson L; Williams A; Sufit RL; Brooks BR
Neurol Clin; 1987 May; 5(2):269-90, vi. PubMed ID: 11681403
[TBL] [Abstract][Full Text] [Related]
13. The acute cardiovascular actions of intravenous thyrotrophin releasing hormone (TRH) in man are mediated by non-catecholaminergic mechanisms.
Bouloux PM; Corsello S; Besser M; Grossman A
Br J Clin Pharmacol; 1996 Aug; 42(2):225-32. PubMed ID: 8864322
[TBL] [Abstract][Full Text] [Related]
14. The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers.
Molchan SE; Mellow AM; Hill JL; Weingartner H; Martinez R; Vitiello B; Sunderland T
J Psychopharmacol; 1992 Jan; 6(4):489-500. PubMed ID: 22291397
[TBL] [Abstract][Full Text] [Related]
15. Multiple injections of thyrotropin releasing hormone fail to reverse learning and memory deficits in rats with lesions of the nucleus basalis of meynert.
Santucci AC; Perez S
Behav Brain Res; 2002 Nov; 136(2):433-8. PubMed ID: 12429405
[TBL] [Abstract][Full Text] [Related]
16. Effects of thyrotropin-releasing hormone on acute experimental traumatic head injury in cats.
Wang GL; Zhu C
Chin Med J (Engl); 1991 Nov; 104(11):939-44. PubMed ID: 1800036
[TBL] [Abstract][Full Text] [Related]
17. The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers.
Coupland NJ; Bailey JE; Glue P; Nutt DJ
Br J Clin Pharmacol; 1995 Sep; 40(3):223-9. PubMed ID: 8527283
[TBL] [Abstract][Full Text] [Related]
18. Thyrotropin-releasing hormone in acute pancreatitis. A preliminary report.
Kiviniemi H; Laitinen S; Ståhlberg M; Larmi M; Kairaluoma M
Acta Chir Scand; 1986 Jan; 152():43-7. PubMed ID: 2420106
[TBL] [Abstract][Full Text] [Related]
19. The involvement of central cholinergic mechanisms in cardiovascular responses to intracerebroventricular and intravenous administration of thyrotropin-releasing hormone.
Okuda C; Mizobe T; Miyazaki M
Life Sci; 1987 Mar; 40(13):1293-9. PubMed ID: 3104710
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the effects of thyrotropin releasing hormone (TRH) therapy on regional cerebral blood flow in the cerebellar variant of multiple system atrophy using 3DSRT.
Kimura N; Kumamoto T; Masuda T; Nomura Y; Hanaoka T; Hazama Y; Okazaki T
J Neuroimaging; 2011 Apr; 21(2):132-7. PubMed ID: 19674246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
